'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design.

Prasad Nishtala; Teyuan Chyou

'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design.

University of Otago

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

Original language	English
Title of host publication	Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting
Publisher	apsa/ascept
Pages	2-2
Number of pages	1
Publication status	Published - 31 Dec 2017

Bibliographical note

Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting.</em> (pp. 2). Retrieved from https://www.asceptasm.com/

Access to Document

https://www.asceptasm.com/

Cite this

Nishtala, P., & Chyou, T. (2017). 'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design. In Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting (pp. 2-2). apsa/ascept. https://www.asceptasm.com/

'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design. / Nishtala, Prasad; Chyou, Teyuan.
Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. apsa/ascept, 2017. p. 2-2.

Research output: Chapter or section in a book/report/conference proceeding › Chapter in a published conference proceeding

Nishtala, P & Chyou, T 2017, 'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design. in Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. apsa/ascept, pp. 2-2. <https://www.asceptasm.com/>

@inproceedings{ef6fc5e85af44977a3faee8d88463237,

title = "'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design.",

author = "Prasad Nishtala and Teyuan Chyou",

note = "Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting.</em> (pp. 2). Retrieved from https://www.asceptasm.com/",

year = "2017",

month = dec,

day = "31",

language = "English",

pages = "2--2",

booktitle = "Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting",

publisher = "apsa/ascept",

}

TY - GEN

T1 - 'Real world' haemorrhagic rates for antithrombotics use in a self-controlled case series design.

AU - Nishtala, Prasad

AU - Chyou, Teyuan

N1 - Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting.</em> (pp. 2). Retrieved from https://www.asceptasm.com/

PY - 2017/12/31

Y1 - 2017/12/31

M3 - Chapter in a published conference proceeding

SP - 2

EP - 2

BT - Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting

PB - apsa/ascept

ER -